These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14511018)

  • 21. Multiple nodules and plaques on the face and trunk. Cutaneous Rosai-Dorfman disease (RDD).
    Wartman DG; Perry A; Werchniak AE
    Arch Dermatol; 2006 Nov; 142(11):1501-6. PubMed ID: 17116845
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of purely cutaneous ​Rosai-Dorfman disease with topical rapamycin.
    Balestri R; Magnano M; Pedrolli A; Girardelli CR; Rech G
    Clin Exp Dermatol; 2023 Apr; 48(5):545-547. PubMed ID: 36647561
    [No Abstract]   [Full Text] [Related]  

  • 23. An unusual case of multiple cutaneous Rosai-Dorfman disease involving two separate parts of the body.
    Jia J; Tian Q; Zhang H; Zheng Y
    Int J Dermatol; 2017 May; 56(5):576-578. PubMed ID: 28255989
    [No Abstract]   [Full Text] [Related]  

  • 24. Rosai-Dorfman disease presenting with nasal, nodal and multiple cutaneous involvements responding to a combination of systemic steroid and low-dose thalidomide therapy.
    Kalay Yildizhan I; Sanli H; Akay BN; Erol HM; Kuzu I; Kırmızı A; Cengiz Seval G
    Dermatol Ther; 2021 Jul; 34(4):e14988. PubMed ID: 33993590
    [No Abstract]   [Full Text] [Related]  

  • 25. Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomide.
    Grimaldi M; Perino F; Moretta G; Antonelli F; Paradisi A; Ricci F; Abeni D; Didona B; Fania L
    Dermatol Ther; 2022 Nov; 35(11):e15864. PubMed ID: 36175132
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractory cutaneous Rosai-Dorfman disease responsive to cryotherapy.
    Fumerton R; Ball N; Zhou Y
    Cutis; 2011 Jun; 87(6):296-9. PubMed ID: 21838087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Rosai-Dorfman disease.
    Rubenstein MA; Farnsworth NN; Pielop JA; Orengo IF; Curry JL; Drucker CR; Hsu S
    Dermatol Online J; 2006 Jan; 12(1):8. PubMed ID: 16638376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous Rosai-Dorfman disease and annular elastolytic giant cell granuloma successively appearing in a case.
    Kim YJ; Lee KH; Lee WJ; Won CH; Chang SE; Choi JH; Lee MW
    J Dermatol; 2019 Dec; 46(12):e470-e472. PubMed ID: 31392739
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic challenge of dapsone in the treatment of purely cutaneous Rosai-Dorfman disease.
    Chang HS; Son SJ; Cho KH; Lee JH
    Clin Exp Dermatol; 2011 Jun; 36(4):420-2. PubMed ID: 21564180
    [No Abstract]   [Full Text] [Related]  

  • 30. Cutaneous involvement of pre-existing Rosai-Dorfman disease via post-herpetic isotopic response.
    Malviya N; Marzuka A; Maamed-Tayeb M; Le L; Vandergriff T
    J Cutan Pathol; 2016 Dec; 43(12):1211-1214. PubMed ID: 27611178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous Rosai-Dorfman disease.
    Parrent T; Clark T; Hall D
    Cutis; 2012 Nov; 90(5):237-8. PubMed ID: 23270193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine.
    Tasso M; Esquembre C; Blanco E; Moscardó C; Niveiro M; Payá A
    Pediatr Blood Cancer; 2006 Oct; 47(5):612-5. PubMed ID: 16302214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of Rosai-Dorfman disease using ALA-PDT.
    Sun L; Shi J; Su Z; Zhang M; Lu Y
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():128-129. PubMed ID: 29197644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous rosai-dorfman disease and morphea: coincidence or association?
    Chappell JA; Burkemper NM; Frater JL; Hurley MY
    Am J Dermatopathol; 2009 Jul; 31(5):487-9. PubMed ID: 19542928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.
    Tjiu JW; Hsiao CH; Tsai TF
    Br J Dermatol; 2003 May; 148(5):1060-1. PubMed ID: 12786846
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Pagel JM; Lionberger J; Gopal AK; Sabath DE; Loeb K
    Am J Hematol; 2007 Dec; 82(12):1121-2. PubMed ID: 17696200
    [No Abstract]   [Full Text] [Related]  

  • 37. Dermatoscopic findings in cutaneous Rosai-Dorfman disease and response to low-dose thalidomide.
    Wang F; Zhou H; Luo DQ; Han JD; Chen MK
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):350-2. PubMed ID: 24580965
    [No Abstract]   [Full Text] [Related]  

  • 38. Extensive purely cutaneous Rosai-Dorfman disease responsive to acitretin.
    Mebazaa A; Trabelsi S; Denguezli M; Sriha B; Belajouza C; Nouira R
    Int J Dermatol; 2007 Nov; 46(11):1208-10. PubMed ID: 17988346
    [No Abstract]   [Full Text] [Related]  

  • 39. Subconjunctival masses associated with central nervous system rosai-dorfman disease.
    Cavuoto K; Galor A; Dubovy SR; Gregori N; McCarthy M
    Cornea; 2011 Feb; 30(2):237-40. PubMed ID: 20847659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of cutaneous Rosai-Dorfman.
    Prada-García MDC; Perandones-González H; Linares-Navarro R
    Int J Dermatol; 2022 Nov; 61(11):e433-e434. PubMed ID: 35073424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.